West Pharmaceutical
289 hedge funds and large institutions have $5.07B invested in West Pharmaceutical in 2016 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 91 increasing their positions, 111 reducing their positions, and 14 closing their positions.
300% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 14
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
15% more funds holding
Funds holding: 251 → 289 (+38)
7% more capital invested
Capital invested by funds: $4.75B → $5.07B (+$321M)
2.8% less ownership
Funds ownership: 94.13% → 91.34% (-2.8%)
18% less repeat investments, than reductions
Existing positions increased: 91 | Existing positions reduced: 111
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CWAM
Columbia Wanger Asset Management
Chicago,
Illinois
|
+$44.2M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$20.5M |
| 3 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$18.4M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$18.1M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$69.9M |
| 2 |
State Street
Boston,
Massachusetts
|
-$38.7M |
| 3 |
Northern Trust
Chicago,
Illinois
|
-$37.6M |
| 4 |
Renaissance Technologies
New York
|
-$34.1M |
| 5 |
RIM
RS Investment Management
San Francisco,
California
|
-$24.3M |
WST Hedge Fund Activity: Q2 2016 in Review
289 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q2 2016, worth a combined $5.07B — up 6.8% from $4.75B a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new WST positions and 14 closed out — a net gain of 42 holders — while 91 added to existing stakes and 111 trimmed.
The largest buyer was Columbia Wanger Asset Management, adding an estimated $44.2M. The largest seller was BlackRock Fund Advisors, cutting an estimated $69.9M.
- 289 institutional investors held West Pharmaceutical (WST) as of Q2 2016, up from 251 in Q1 2016.
- Funds reported $5.07B of West Pharmaceutical stock for Q2 2016, up 6.8% quarter-over-quarter.
- 56 funds opened new West Pharmaceutical positions in Q2 2016 and 14 closed out, a net change of +42 holders.
- The largest West Pharmaceutical buyer in Q2 2016 was Columbia Wanger Asset Management, an estimated $44.2M added.
- The largest West Pharmaceutical seller in Q2 2016 was BlackRock Fund Advisors, an estimated $69.9M sold.
Based on aggregated 13F filings for Q2 2016.